Save 20% on Press Releases and More with NNW Prime! Click to View Details
MondayFeb 27, 2017 10:23 am

NetworkNewsBreaks – ChineseInvestors.com, Inc. (CIIX) CEO Presents at Shandong Yibao Biologics Conference

Market analysis company ChineseInvestors.com, Inc. (OTCQB: CIIX) this morning announced that CEO Warren Wang recently attended Shandong Yibao Biologics Co. Ltd.’s annual conference, where he was invited to deliver a speech celebrating Yibao Biologics’ 18th anniversary. A modern high-tech enterprise specializing in the research, production and sale of health care products, Yibao Biologics hosts an annual direct sales conference to discuss the development and prospects of Chinese health products enterprises in the United States. “The market for direct selling of natural products in the United States has considerable depth, and varies from the Chinese market in many ways,” Wang stated…

Continue Reading

MondayFeb 27, 2017 9:49 am

NetworkNewsBreaks – eXp World Holdings, Inc. (EXPI) Scheduled to Present at 29th Annual ROTH Capital Partners Conference

eXp World Holdings, Inc. (OTCQB: EXPI), holding company for eXp Realty LLC, this morning announced that it has been invited to present at the 29th Annual ROTH Capital Partners Conference, which is set to take place from March 12-15, 2017, at the Ritz-Carlton, Laguna Niguel in Dana Point, California. The company’s management team is scheduled to present on Monday, March 13 at 8:00 AM Pacific Time. For those unable to attend, a webcast of the presentation will be made available at http://wsw.com/webcast/roth31/expi. In addition to its presentation, the EXPI team is expected to host one-on-one meetings with prospective investors throughout…

Continue Reading

FridayFeb 24, 2017 11:28 am

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on February 24, 2017

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: RMGN 10.64% – News: Converts Visual Supply Chain pilot with initial rollout sales order for global manufacturer ORPN 4.39% – News: Posts Q4, FY 2016 financial results VPRB 4.08% – News: Launches the MINIMAX Key FOB Battery AEMD 3.82% – News: CEO releases note on Bill Gates’ recent statement on bioterrorism threat JVA 3.45% – News: Acquires Comfort Foods Inc. ITEK 3.23% – News: Presenting at the American Glaucoma Society 2017 Annual Meeting March…

Continue Reading

FridayFeb 24, 2017 11:23 am

NetworkNewsBreaks – Function(x), Inc. (NASDAQ: FNCX) Prices $4.8M Common Stock Offering, Hits 52-Week Low

Function(x) (NASDAQ: FNCX) shares dropped to $1.02 this morning after the social publishing and interactive media platform priced its underwritten public offering of 4,571,428 shares of its common stock at a public price of $1.05 per share. Additionally, the company has allowed the underwriters a 45-day option to purchase up to an additional 685,714 shares of common stock to cover over-allotments, if necessary. Before deducting underwriting discounts, commissions and other estimated offering expenses, the gross proceeds are expected to be approximately $4,800,000. Subject to customary closing conditions, the offering is expected to close on March 1, 2017. To view the…

Continue Reading

FridayFeb 24, 2017 11:17 am

NetworkNewsBreaks – Cempra, Inc. (NASDAQ: CEMP) – Phase 3 Study of Fusidic Acid Achieves Primary Endpoint; Shares Rise

Cempra (NASDAQ: CEMP) shares rose 38% following the company’s report of positive topline results from a phase 3 study of oral fusidic acid. The study, which took place in 716 patients with acute bacterial skin and skin structure infections, demonstrated that fusidic acid was well tolerated. Additionally, the study realized the primary endpoint, demonstrating non-inferiority (NI) (10% NI margin) of oral fusidic acid compared to oral linezolid for early clinical response in the intent to treat patient population. The company plans to submit the full data from this study for presentation at an upcoming scientific forum. “We are excited that…

Continue Reading

FridayFeb 24, 2017 11:13 am

NetworkNewsBreaks – Intellipharmaceutics International, Inc. (NASDAQ: IPCI) Shares Higher on FDA Approval of Two Strengths of Generic Glucophage® XR

Intellipharmaceutics International (NASDAQ: IPCI) shares were up 27% this morning following news that it has received final approval for its abbreviated new drug application (ANDA) for metformin hydrochloride extended release tablets in the 500 mg and 750 mg strengths from the U.S. Food and Drug Administration (FDA). Metformin hydrochloride extended release is a generic equivalent for the matching strengths of the branded product Glucophage® XR, which is sold in the United States by Bristol-Myers Squibb and indicated for use in the management of type 2 diabetes. "FDA approval of our application for a generic version of Glucophage® XR provides further…

Continue Reading

FridayFeb 24, 2017 11:10 am

NetworkNewsBreaks – Auris Medical’s (NASDAQ: EARS) AM-111 Receives FDA Fast Track Designation to Treat Acute Sensorineural Hearing Loss

Auris Medical (NASDAQ: EARS) shares rose 13% this morning on news of the reception of Fast Track designation for AM-111 in the treatment of acute sensorineural hearing loss (ASNHL) from the U.S. Food and Drug Administration (FDA). The company is currently evaluating AM-111 in two phase 3 clinical trials. The first is the HEALOS trial, which is being conducted in several European and Asian countries. Auris Medical expects to complete enrollment in the second quarter of 2017 and report top-line results from this trial in the third quarter of 2017. The second trial, ASSENT, is being conducted in the U.S.,…

Continue Reading

ThursdayFeb 23, 2017 11:30 am

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on February 23, 2017

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: PTX 50.36% – News: Receives favorable opinion in Zohydro® ER ANDA litigation NVFY 29.28% – News: Reports over 1,000 individuals paid and completed training on Nova-Mart in February HMNY 16.99% – News: Launches free hate crime mapping on RedZone Map ETST 16.00% – News: Begins composition of 2 new pharmaceutical drugs, 3 nutraceutical patent studies AVEO 12.67% – News: Passes the first safety review for TIVO-3 by SMC EQUR 9.23% – News: Receives FDA…

Continue Reading

ThursdayFeb 23, 2017 11:28 am

NetworkNewsBreaks – MabVax Therapeutics Holdings, Inc. (NASDAQ: MBVX) Receives Regulatory Green Light for Clinical Trial of Pancreatic Cancer Candidate

MabVax Therapeutics (NASDAQ: MBVX) is trading higher after announcing it has received authorization from the FDA for the initiation of a phase I clinical trial with MVT-1075 as a therapeutic treatment for pancreatic cancer. MVT-1075 is the company's novel, fully human antibody radioimmunotherapy. In this initial phase I trial the company plans to evaluate the safety, dosimetry, and pharmacokinetics of MVT-1075 with patient disease status evaluated based on tumor measurements using RECIST 1.1 criteria. The company intends to initiate the phase I clinical trial in the first half of 2017. "We are executing on the development strategy we have outlined…

Continue Reading

ThursdayFeb 23, 2017 11:26 am

NetworkNewsBreaks – eXp World Holdings, Inc. (EXPI) Adds Over 100 New Agents and Brokers in Tough Climate

While market reports show low inventory of houses on the market, eXp World Holdings doesn’t seem to be affected by the overall concern for real estate businesses in the United States. In fact, the company continues to grow. “Although the end of 2016 showed cause for concern for real estate businesses across the country, inventory for January moved at a 4% faster annual rate (http://nnw.fm/obP83). This stronger than usual off-season has left a low volume of available homes for sale with very high prices. But this dip in volume has not halted the rising interest in eXp World Holdings, Inc.…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000